Dr Alex Lyness
Head of Innovation Strategy & Applied Research Business Development Americas

About

Alex Lyness, PhD, is Head of Innovation Strategy & Applied Research Business Development Americas, at SHL Medical. Dr Lyness is based in Philadelphia (US).

Before SHL he was Business Development Director Drug Delivery at TTP and prior to that he was at West Pharmaceutical Services, where he gained extensive experience in the research, development and commercialisation of novel drug delivery devices and containment systems.

Dr Lyness obtained his PhD while working at a drug delivery start-up in Oxford (UK) and is a Chartered Engineer with the Institution of Mechanical Engineers.

Contributions

EXPERT VIEW

SCALING GLP-1 DRUGS WITHOUT A MOUNTAIN OF WASTE

Matt Parker, Simon Lyons and Alex Lyness, look at how the continued success of glucagon-like peptide-1 drugs is bringing into focus the need for environmentally sustainable self-injection systems. They discuss whether reloadable autoinjectors could be the way to boost sustainability, lower cost per dose, and match the scale and rate of adoption of these new therapies.